Cai Lay Veterinary Pharmaceutical Joint Stock Company (HNX: MKV)
Health Care · Pharmaceuticals · VN
₫13,200.00
+10.00% today · +41.9% 1Y
Cai Lay Veterinary Pharmaceutical Joint Stock Company (HNX: MKV) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.54M.
Over the last twelve months the share price has gained 41.9%, trading between 9.30K and 26.40K.
Tweenvest scores Cai Lay Veterinary Pharmaceutical Joint Stock Company across four factors: quality 89/100, value 87/100. Its strongest factor is quality.
MKV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.54M
- Revenue (TTM)
- $5.85M
- P/E
- 4.43
- EPS
- 2,978.26
- Dividend yield
- —
- Beta (5Y)
- 0.48
- 52-week high
- ₫26,400.00
- 52-week low
- ₫9,300.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SciSparc Ltd.NasdaqCM: SPRC | $2.60M | $4.43 | -0.89% |
| XORTX Therapeutics Inc.NasdaqCM: XRTX | $2.56M | $1.74 | +23.40% |
| Welcure Drugs and Pharmaceuticals LimitedBSE: 524661 | $2.55M | Rs0.20 | -4.76% |
| Argent BioPharma LimitedASX: RGT | $2.55M | AU$0.03 | +3.33% |
| Double Bond Pharmaceutical International AB (publ)XSAT: DBP B | $2.51M | Skr0.11 | +3.70% |
| Jaguar Health, Inc.NasdaqCM: JAGX | $2.49M | $4.45 | -7.10% |
| Société des Industries Pharmaceutiques de Tunisie - S.A.BVMT: SIPHA | $2.38M | DT3.97 | -12.56% |
| Pharmesis International Ltd.SGX: BFK | $2.36M | S$0.10 | — |
Figures last refreshed Oct 11, 2026.